Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| 1 |
Apple
AAPL
|
+$684M |
| 2 |
American Tower
AMT
|
+$367M |
| 3 |
TJX Companies
TJX
|
+$337M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$335M |
| 5 |
Arista Networks
ANET
|
+$310M |
Top Sells
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
+$986M |
| 2 |
Vanguard Russell 1000 Growth ETF
VONG
|
+$658M |
| 3 |
Qualcomm
QCOM
|
+$570M |
| 4 |
United Parcel Service
UPS
|
+$522M |
| 5 |
Eaton
ETN
|
+$456M |
Sector Composition
| 1 | Technology | 25.23% |
| 2 | Financials | 10.48% |
| 3 | Healthcare | 9.58% |
| 4 | Industrials | 8.24% |
| 5 | Consumer Discretionary | 7.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3176
Nuveen Real Asset Income & Growth Fund
JRI
$384M
| $796K | ﹤0.01% |
65,417
-657
| -1% | -$8K |
|
3177
Compass
COMP
$4.83B
| $796K | ﹤0.01% |
221,124
+8,400
| +4% | +$30.2K |
|
3178
Fate Therapeutics
FATE
$115M
| $795K | ﹤0.01% |
242,432
-41,958
| -15% | -$138K |
|
3179
Nuveen Dynamic Municipal Opportunities Fund
NDMO
$621M
| $795K | ﹤0.01% |
73,589
-4,755
| -6% | -$51.4K |
|
3180
Nuveen Real Estate Income Fund
JRS
$236M
| $794K | ﹤0.01% |
98,668
-3,928
| -4% | -$31.6K |
|
3181
Anika Therapeutics
ANIK
$121M
| $793K | ﹤0.01% |
31,321
-8,203
| -21% | -$208K |
|
3182
Frontline
FRO
$5.02B
| $791K | ﹤0.01% |
30,847
+295
| +1% | +$7.57K |
|
3183
Nuveen Preferred Securities & Income Opportunities Fund
JPI
$291M
| $791K | ﹤0.01% |
40,305
+4,158
| +12% | +$81.6K |
|
3184
Allogene Therapeutics
ALLO
$246M
| $788K | ﹤0.01% |
338,045
+149,005
| +79% | +$347K |
|
3185
BlackRock Health Sciences Trust II
BMEZ
$903M
| $787K | ﹤0.01% |
51,242
-10,808
| -17% | -$166K |
|
3186
iShares Global REIT ETF
REET
$3.87B
| $786K | ﹤0.01% |
33,818
-113,026
| -77% | -$2.63M |
|
3187
Revolve Group
RVLV
$1.67B
| $785K | ﹤0.01% |
49,359
-5,384
| -10% | -$85.7K |
|
3188
Howard Hughes
HHH
$4.68B
| $784K | ﹤0.01% |
12,692
-179
| -1% | -$11.1K |
|
3189
FlexShares International Quality Dividend Index Fund
IQDF
$804M
| $784K | ﹤0.01% |
31,509
-1,665
| -5% | -$41.4K |
|
3190
Universal Technical Institute
UTI
$1.48B
| $783K | ﹤0.01% |
49,756
-104,568
| -68% | -$1.64M |
|
3191
8x8 Inc
EGHT
$285M
| $782K | ﹤0.01% |
352,354
-64,959
| -16% | -$144K |
|
3192
Byline Bancorp
BY
$1.32B
| $780K | ﹤0.01% |
32,874
| – | – |
|
|
FLIC
3193
DELISTED
First of Long Island Corp
FLIC
| $780K | ﹤0.01% |
77,855
+14,830
| +24% | +$149K |
|
3194
BlackRock MuniAssets Fund
MUA
$439M
| $777K | ﹤0.01% |
67,003
-8,942
| -12% | -$104K |
|
3195
iShares USD Green Bond ETF
BGRN
$419M
| $776K | ﹤0.01% |
16,666
-57
| -0.3% | -$2.66K |
|
3196
Constellium
CSTM
$2.02B
| $776K | ﹤0.01% |
41,168
-880,910
| -96% | -$16.6M |
|
3197
iShares MSCI Netherlands ETF
EWN
$256M
| $770K | ﹤0.01% |
+15,335
| New | +$770K |
|
|
PFL
3198
PIMCO Income Strategy Fund
PFL
$384M
| $770K | ﹤0.01% |
94,495
+495
| +0.5% | +$4.03K |
|
3199
Nuveen Churchill Direct Lending
NCDL
$772M
| $769K | ﹤0.01% |
+44,192
| New | +$769K |
|
3200
BlackRock Investment Quality Municipal Trust
BKN
$194M
| $767K | ﹤0.01% |
64,205
-205
| -0.3% | -$2.45K |
|